Accessible model predicts response in hormone receptor positive HER2 negative breast cancer receiving neoadjuvant chemotherapyLuca Mastrantoni, Emilio Bria, Elena Di Monte et al.|npj Breast Cancer|2025Cited by 9
Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant ChemotherapyGiovanna Garufi, Emilio Bria, Luca Mastrantoni et al.|Research Square|2024Cited by 0